Peptide blends

KLOW vs GLOW Peptide Blends

What is in each blend, how they differ, what one dose actually contains, and what the research and the law say about them.

  • KLOW: 4 peptides, GLOW: 3
  • Neither blend has been studied
  • Blends not covered by the new HHS policy
A fit young man and woman stretching together after a workout in a bright studio

Educational content only, not medical advice. KLOW and GLOW are not FDA-approved and are sold as research chemicals. Doses below are vendor and community figures, not recommendations. Talk to a licensed clinician first.

The short answer

GLOW is a three-peptide blend of GHK-Cu, BPC-157 and TB-500. KLOW is the same blend plus KPV, an anti-inflammatory peptide. That fourth ingredient is the only real difference.

Both are marketed for recovery, skin quality and tissue repair. Each ingredient has its own research history, mostly in cells and animals, but no study has tested either blend. A blend also locks you into a fixed ratio, so you cannot change the dose of one peptide without changing all of them.

What is in each vial

Typical vial sizes sold by most vendors.

KLOW · 80mg

Four peptides

  • GHK-Cu50mg
  • BPC-15710mg
  • TB-50010mg
  • KPV10mg

Pitched for: repair, skin and inflammation

GLOW · 70mg

Three peptides

  • GHK-Cu50mg
  • BPC-15710mg
  • TB-50010mg

Pitched for: repair and skin

Amounts can vary by vendor. Check the label and the certificate of analysis, which should list each peptide separately. See how to read a COA.

The four ingredients

What each one is studied for, and how strong the evidence is.

GHK-Cu

A copper peptide found naturally in the body. Studied for collagen production, wound healing and skin remodeling, with the strongest data for topical use.

Lab, animal, topical data GHK-Cu guide

BPC-157

A gastric peptide fragment studied for tendon, ligament, muscle and gut repair. A 2025 review found mostly animal data and very few human studies.

Mostly animal data BPC-157 guide

TB-500

A fragment of thymosin beta-4, a protein involved in cell migration, blood vessel growth and wound repair.

Mostly animal data TB-500 guide

KLOW only

KPV

A three-amino-acid fragment of alpha-MSH. In mouse models of colitis, it reduced intestinal inflammation.

Animal data KPV guide

KLOW vs GLOW side by side

KLOWGLOW
PeptidesGHK-Cu, BPC-157, TB-500, KPVGHK-Cu, BPC-157, TB-500
Typical vial80mg70mg
Main pitchRepair, skin, inflammationRepair and skin
Studies of the blendNoneNone
FDA statusNot approvedNot approved
Compoundable as a blendNoNo
Tested sportBanned (BPC-157, TB-500)Banned (BPC-157, TB-500)

What one dose actually contains

The fixed ratio is the part most people overlook.

Vendor guides commonly suggest mixing the vial with 2.5 to 3mL of bacteriostatic water and working up to about 15 units a day on an insulin syringe. Because every unit carries all the peptides in the same ratio, here is what 15 units contains when each vial is mixed with 3mL:

  • KLOW (80mg in 3mL): about 2.5mg GHK-Cu plus 500mcg each of BPC-157, TB-500 and KPV
  • GLOW (70mg in 3mL): about 2.5mg GHK-Cu plus 500mcg each of BPC-157 and TB-500

On its own, injected GHK-Cu is commonly reported at about 1 to 2mg a day. So a blend dose chosen for its BPC-157 content gives you more GHK-Cu than many single-peptide protocols use. Mixing with less water makes every unit stronger.

Run your own vial size and water volume through the peptide calculator. These are vendor figures, not clinical doses.

Two small glass vials of pale blue reconstituted peptide solution on a white marble counter

How people choose

There is no head-to-head evidence, so the choice usually comes down to KPV:

  • GLOW appeals to people focused mainly on skin, hair and general recovery.
  • KLOW appeals to people who also want KPV for inflammation or gut comfort.
  • Separate vials suit anyone who wants to control each dose, find out which peptide is causing a side effect, or use a pharmacy.

If recovery is the main goal, the two-peptide Wolverine stack (BPC-157 plus TB-500) is the simpler starting point. For gut-focused use, see BPC-157 vs KPV.

A young woman with clear glowing skin applying serum in a bright bathroom mirror

Side effects and quality

  • Blue color and sting: GHK-Cu is a copper complex, so the mixed solution is usually blue. Users often report stinging or burning at the injection site.
  • Common complaints: redness, itching or bumps at the site, flushing, fatigue and headache, based on user reports rather than trials.
  • Harder to verify: a blend needs each peptide tested separately. Research-chemical products are not checked for identity, purity or sterility, and independent testing has found wide variation.
  • Talk to a clinician first if you are pregnant, have a cancer history, a copper metabolism disorder such as Wilson's disease, or take other medications.

More in peptide side effects and are peptides safe?

A young man reviewing a lab test report on his laptop at a bright desk

Where to buy

Compare prescription compounding and research-grade sources for each:

Common question: why does KLOW burn hours later?

A frequent report is an injection that feels fine at first, then burns an hour or two later. Read why a KLOW injection can burn hours later, what people try, and the signs that need a doctor, or browse more community questions.

Frequently asked questions

What is the difference between KLOW and GLOW?

Both blends contain GHK-Cu, BPC-157 and TB-500. KLOW adds a fourth peptide, KPV, which is studied for anti-inflammatory effects, especially in the gut. A typical KLOW vial is 80mg (50mg GHK-Cu plus 10mg each of BPC-157, TB-500 and KPV), and a typical GLOW vial is 70mg (50mg GHK-Cu plus 10mg each of BPC-157 and TB-500).

What is KLOW peptide used for?

KLOW is marketed for tissue repair, skin quality and inflammation, combining GHK-Cu for collagen and skin remodeling, BPC-157 and TB-500 for tissue repair, and KPV for inflammation. No study has tested the KLOW blend itself. The evidence comes from separate research on each ingredient, mostly in cells and animals.

Is KLOW or GLOW better?

Neither has been shown to be better, because neither blend has been studied. The only difference is KPV. People who are mainly interested in inflammation or gut comfort tend to choose KLOW, and people focused on skin and recovery often choose GLOW. Both lock you into a fixed ratio of ingredients.

How much KLOW do people take?

Vendor guides commonly suggest mixing an 80mg KLOW vial with 2.5 to 3mL of bacteriostatic water and starting around 7 to 8 units a day, working up to about 15 units. At 3mL, 15 units contains roughly 2.5mg of GHK-Cu and 500mcg each of BPC-157, TB-500 and KPV. These are community and vendor figures, not clinical doses.

Why does KLOW turn blue and sting?

GHK-Cu is a copper complex, so the mixed solution is usually blue. Many users report that GHK-Cu stings or burns at the injection site, and because the blends contain a large amount of it, injection discomfort is one of the most common complaints about KLOW and GLOW.

Are KLOW and GLOW legal?

Neither blend is FDA-approved, and both are sold as research chemicals. Under the draft HHS policy announced in October 2026, licensed 503A pharmacies can compound BPC-157, TB-500 and KPV by prescription, but only one ingredient per product, so blends are not covered. GHK-Cu is not part of that policy, and FDA's advisory committee plans to discuss it before the end of February 2027.

Are KLOW and GLOW banned in sport?

Both blends contain BPC-157 and TB-500, which the World Anti-Doping Agency prohibits at all times. Athletes in tested sport should treat both blends as banned.

Is it better to take the peptides separately?

Separate vials let you set the dose of each peptide on its own and stop one if it causes problems, which a blend cannot do. Blends are simpler, with one vial and one injection. Separate products are also the only way to get any of these peptides through a pharmacy under the new HHS policy.

Track what a blend is doing

Log every dose, injection site and check-in, and see whether your skin, recovery or symptoms actually change. Free.

Looking for KLOW or GLOW? Our KLOW and GLOW buying guide lists both from HLX Labs. BioStackIQ earns a commission on purchases through those links.

Sources

  1. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018. PMID 29986520
  2. Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008. PMID 18644225
  3. Vasireddi N, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J. 2025. PMID 40756949
  4. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005. PMID 16153892
  5. Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008. PMID 18061177
  6. Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis. 2008. PMID 18092346
  7. Mendias CL. Evaluation of Research Grade Peptides Marketed Directly to Consumers Reveals Extensive Variability in Purity and Measured Abundance. Preprints.org (not peer-reviewed). 2026. doi.org
  8. World Anti-Doping Agency. The Prohibited List. wada-ama.org

This content is for informational purposes only and is not medical advice. KLOW and GLOW are not FDA-approved, and dosing figures reflect vendor and community guides, not clinical guidelines. Always consult a qualified healthcare provider before starting any peptide.